Brookfield still pursuing Grifols deal, Bloomberg reports
EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...
Grifols falls on report Brookfield delays offer on funding issues
Grifols (NASDAQ:GRFS) dropped 3% after a report that Brookfield (BAM) is delaying a takeover bid due to issues raising money ...
New Atlas9d
World-first treatment to prevent long-term eye damage from mustard gas
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to ...
Grifols (NASDAQ:GRFS) Raised to Strong-Buy at Berenberg Bank
Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...
Grifols receives FDA approval to treat surgical bleeding with FS solution
Grifols (GRFS) announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received ...
news.stocktradersdaily4d
(GRFS) Long Term Investment Analysis
Check the time stamp on this data. Updated AI-Generated Signals for Grifols S.a. (GRFS) available here: GRFS.
Morningstar8d
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasis Grifols surgical bleeding management ...
Yahoo Finance6d
Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations ...
1 man dead, 1 in custody after plasma center shooting, witnesses say shooter warned them
Police were called to the scene about 3 p.m. A man was pronounced dead and another was in custody, officials said.